Sodium–glucose co‐transporter 2 inhibitors as an early, first‐line therapy in patients with heart failure and reduced ejection fraction
D Tomasoni, GC Fonarow, M Adamo… - European journal of …, 2022 - Wiley Online Library
Sodium–glucose co‐transporter 2 (SGLT2) inhibitors have recently been recommended as a
foundational therapy for patients with heart failure (HF) and reduced ejection fraction …
foundational therapy for patients with heart failure (HF) and reduced ejection fraction …
Optimizing foundational therapies in patients with HFrEF: how do we translate these findings into clinical care?
Given the high risk of adverse outcomes in patients with heart failure and reduced ejection
fraction (HFrEF), there is an urgent need for the initiation and titration of guideline-directed …
fraction (HFrEF), there is an urgent need for the initiation and titration of guideline-directed …
Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial
Background Dietary restriction of sodium has been suggested to prevent fluid overload and
adverse outcomes for patients with heart failure. We designed the Study of Dietary …
adverse outcomes for patients with heart failure. We designed the Study of Dietary …
Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms
K Huang, X Luo, B Liao, G Li, J Feng - Cardiovascular Diabetology, 2023 - Springer
Among the complications of diabetes, cardiovascular events and cardiac insufficiency are
considered two of the most important causes of death. Experimental and clinical evidence …
considered two of the most important causes of death. Experimental and clinical evidence …
Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease
H Liu, VS Sridhar, J Boulet, A Dharia, A Khan… - Metabolism, 2022 - Elsevier
Abstract Type 2 diabetes (T2D) is one of the most common causes of chronic kidney disease
(CKD) and cardiovascular (CV) disease. Until recently, glycemic and BP control were the …
(CKD) and cardiovascular (CV) disease. Until recently, glycemic and BP control were the …
Prevalence, outcomes and costs of a contemporary, multinational population with heart failure
Objective Digital healthcare systems could provide insights into the global prevalence of
heart failure (HF). We designed the CardioRenal and Metabolic disease (CaReMe) HF study …
heart failure (HF). We designed the CardioRenal and Metabolic disease (CaReMe) HF study …
A systematic review and meta-analysis of beta-blockers and renin–angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or …
C Lewinter, TH Nielsen, LR Edfors, C Linde… - European heart …, 2022 - academic.oup.com
Aims Trastuzumab and anthracyclines, often used in the treatment of breast cancer, may
impair myocardial function, and reduce left ventricular ejection fraction (LVEF), potentially …
impair myocardial function, and reduce left ventricular ejection fraction (LVEF), potentially …
STICH3C: rationale and study protocol
SE Fremes, G Marquis-Gravel… - Circulation …, 2023 - Am Heart Assoc
BACKGROUND: Coronary artery bypass grafting (CABG) is the recommended mode of
revascularization in patients with ischemic left ventricular dysfunction (iLVSD) and …
revascularization in patients with ischemic left ventricular dysfunction (iLVSD) and …
European Society of Cardiology quality indicators for the care and outcomes of adults with heart failure. Developed by the Working Group for Heart Failure Quality …
Aims To develop a suite of quality indicators (QIs) for the evaluation of the quality of care for
adults with heart failure (HF). Methods and results We followed the ESC methodology for QI …
adults with heart failure (HF). Methods and results We followed the ESC methodology for QI …
Medical therapy during hospitalization for heart failure with reduced ejection fraction: the VICTORIA registry
Background For patients hospitalized for heart failure with reduced ejection fraction (HFrEF),
guidelines recommend optimization of medical therapy prior to discharge. The degree to …
guidelines recommend optimization of medical therapy prior to discharge. The degree to …